Keybanc analyst Eric Gonzalez maintains Restaurant Brands Intl (NYSE:QSR) with a Overweight and raises the price target from $75 to $77.
JP Morgan Downgrades C4 Therapeutics to Neutral, Lowers Price Target to $15
JP Morgan analyst Eric Joseph downgrades C4 Therapeutics (NASDAQ:CCCC) from Overweight to Neutral and lowers the price target from $22 to $15.